Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis

Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis

Abstract Background This study aimed to investigate the predictive values of serum biomarkers including absolute eosinophil count (AEC), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) with respect to immune-related adverse events (irAEs) during anti-PD-1/PD-L1 inhibitor...

Full description

Bibliographic Details
Main Authors: Yan Ma, Xiao Ma, Jingting Wang, Shanshan Wu, Jing Wang, Bangwei Cao
Format: Article
Language:English
Published: BMC 2022-07-01
Series:World Journal of Surgical Oncology
Subjects:
Immunotherapy
Immune-related adverse events
Neutrophil-to-lymphocyte ratio
Platelet-to-lymphocyte ratio
Absolute eosinophil count
Predictive markers
Online Access:https://doi.org/10.1186/s12957-022-02695-y

Internet

https://doi.org/10.1186/s12957-022-02695-y

Similar Items